Novavax (NVAX) Earnings Analysis
Novavax (NVAX) has no confirmed upcoming earnings date. Last quarter (2026-02-26) it beat with EPS 0.11 USD vs -0.66 USD est (+116.7%). It has beaten estimates in 3/3 recent quarters (100%). Trailing P/E -14.65.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does NVAX next report earnings?
No confirmed upcoming earnings date is currently scheduled for NVAX. This page updates as the calendar is published.
NVAX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-26 | 0.11 USD | -0.66 USD | +116.7% | Beat |
| 2025-05-08 | 2.93 USD | 0.71 USD | +312.7% | Beat |
| 2025-02-27 | -0.51 USD | -0.75 USD | +32% | Beat |
Beat rate: 3/3 (100%) over reported quarters with consensus data.
NVAX valuation and analyst view
| Trailing P/E | -14.65 |
|---|---|
| Trailing EPS | -0.53795 USD |
| Price / book | -8.92 |
| Dividend yield | 0.00% |
| Market cap | 1.31B |
| Analyst consensus | Buy (17 buy / 3 hold / 3 sell) |
| Avg price target | 14.5 USD |
Related research pages
Frequently asked questions
When is Novavax (NVAX)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for NVAX. This page updates as the calendar is published.
Did NVAX beat earnings last quarter?
In its 2026-02-26 report, NVAX posted EPS of 0.11 USD versus a -0.66 USD estimate — a beat of 116.7%.
What is NVAX's earnings track record?
Over the last 3 reported quarters with consensus data, NVAX beat estimates 3 times (100%).
What is NVAX's current P/E ratio and EPS?
NVAX trades at a trailing P/E of -14.65 on trailing EPS of -0.5379541390038952 USD.
What do analysts rate NVAX?
Analyst consensus is "Buy" across 23 ratings (0 strong buy, 17 buy, 3 hold, 3 sell, 0 strong sell). Average 12-month price target: 14.5 USD.